Navigation Links
A Novel System For Clinical Banking Of Umbilical Cord Blood

Researchers from Italy have designed a closed circuit, where Umbilical cord blood (UCB) collection and RBC depletion are performed, in order to reduce the contamination risk and to speed the nucleated cell separation//.

Their findings appear in the journal Blood Cells, Molecules, and Diseases (available online 19 August 2005) Umbilical cord blood is a source of hematopoietic progenitor cells and is used as an alternative to the bone marrow or peripheral blood for treatment of several onco-hematological diseases.

Because of the limited number of CD34+ hematopoietic stem cells present in UCB units and of the elevated costs of cryopreservation, it is of paramount importance to select the UCB units that are clinically useful before storage and optimize banking efficiency by designing reliable procedures to process and freeze the selected units.

Nucleated cell (NC) and CD34+ cell content provides useful criteria to select UCB units since clinical data documented that the infused cell load (both NC and CD34+ cells) plays an important role in the successful outcome of transplants. By evaluating volume, CD34+ cell content, NC total amount, and NC density of 117 UCB units, the researchers found a significant association between CD34+ cell content and NC density and total amount, indicating these parameters as useful to decide UCB clinical utility.

Furthermore, the author set up a fast procedure to process UCB units for storage. A system for NC separation and volume reduction of UCB samples in a dedicated, germ-free, closed circuit was developed, where plasma and red blood cells (RBC) depletion was obtained by sedimentation in the presence of a 3.5% Polygeline solution. The separation by the closed circuit, where RBC depletion is obtained by Polygeline sedimentation, proved to be faster and provided a higher recovery of stem cells.

Since Polygeline has been clinically used as a plasma expander and no toxic effects on
'"/>




Page: 1 2

Related medicine news :

1. Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched
2. Novel biopsy technique for prostate cancer
3. Novel computer model for breast cancer
4. Novel research on liver cancer
5. Novel way to fight cancer
6. Novel test for bowel cancer
7. Novel Anti-Neutrophilic Effect produced by Salmeterol in mild asthma patients
8. Novel Therapy for Chronic Problem
9. Blood Sugar Kept In Control By Novel Protein
10. Novel antibiotic dressing developed for improved wound healing
11. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
Post Your Comments:
(Date:12/2/2008)...Newswire-FirstCall/ -- VirtualScopics, Inc.,(Nasd...maging for clinical,trials, today announced that ...d to $14.7 million at the same time a year ago, a ... backlog as the amount remaining to be,recognized...f the studies,included within the backlog ranges ...
(Date:12/2/2008)...t Finds Many Cite Prevention, Shedding, or Sharing...swire-USNewswire/ -- A New Center for State and Lo...es are balancing retiree health care plans and the...th Care in the American States examines how state... health care benefits to central human resources (...
(Date:12/2/2008)...nts treated with radiation prior to surgery for ad...r recurrence and better overall survival rates, ac...rt examined a treatment called neoadjuvant therapy...he spread of cancer, before surgery to remove the ...y and/or radiation. , Neoadjuvant therapy shoul...
(Date:12/2/2008)...port from the Institute of Medicine proposes revis...s to decrease the chances of fatigue-related medic...for these doctors in training. The report does no... from the maximum average of 80 per week set by th...tion (ACGME) in 2003, but rather reduces the maxim...
Breaking Medicine News(10 mins):Health News:VirtualScopics Backlog Rises to a Record $27 Million 2Health News:VirtualScopics Backlog Rises to a Record $27 Million 3Health News:States View Limits on Retiree Health Benefits 2Health News:Revised hours and workloads for medical residents needed to prevent 2Health News:Revised hours and workloads for medical residents needed to prevent 3
... is common among older men. Being the second most ...cer, it is the second leading cause of cancer deat...tection there has been a increase in number of det...reening consists of digital rectal exam and a pros...
...HO's list that travelers should avoid because of S...fe place to live were stunned by this. Toronto is ...as a threat to international health because of the...e in China were also added to its list, which alre...
...in the UK most people believe that asthma is a con...of people with asthma develop the condition in adu... are not recognised and managed in early stages. A...ime at any age. There also exists a possibility wh...
...ound that an active lifestyle with limiting TV tim...survey conducted in the US TV watching results in ... like sewing, playing board games, reading, writin... linked to obesity in children. The health campaig...
Other Medicine News:
(Date:12/1/2008)...with Hypophosphatasia Treated With ENB-0040 at Chi...eg , , MONTREAL, Dec. 1 Eno...ocused on developing novel therapeutics for seriou...nfant patient in its clinical program for hypophos... Replacement Therapy (ERT) with ENB-0040 for the t...
(Date:12/1/2008)...ARD, Denmark, December 1 ...with the intent to procure an MVA-based,third ge...ment Services,Canada, on behalf of the Canadian D...ract to Bavarian Nordic for the delivery of IMVAMU... use IMVAMUNE(R) as part of the,country,s bio-pre...
(Date:11/30/2008)... CHICAGO, Dec. 1 Older...bral blood flow and a greater number of small bloo...ented today at the annual meeting of the Radiologi...he study, conducted at the University of North Ca...pare brain scans of older adults who exercise to b...
(Date:11/27/2008)...finds the majority of acute lymphoblastic leukemia...t the time of diagnosis , , MEMPHIS, Tenn.,...St. Jude Children,s Research Hospital have identif...s of children with acute lymphoblastic leukemia (A...ay to designing treatments for ALL relapse in chil...
Breaking Medicine Technology:Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 2The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 3Exercise Helps Prevent Age-Related Brain Changes in Older Adults 2Exercise Helps Prevent Age-Related Brain Changes in Older Adults 3St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3First Lady Laura Bush Visits AED Netmark Malaria Control Project in Ghana 12394 1First Lady Laura Bush Visits AED Netmark Malaria Control Project in Ghana 12394 2Sikka Software and Dental Economics Announce Alliance 12392 1Sikka Software and Dental Economics Announce Alliance 12392 2Yoga Journal Circulation Increases 5 8 Percent in Second Half of 2007 from Same Period Previous Year 12390 1Yoga Journal Circulation Increases 5 8 Percent in Second Half of 2007 from Same Period Previous Year 12390 2Meadowbrook Insurance Group Inc and ProCentury Corporation Reach Agreement to Merge in 24272 6 Million Transaction 12388 1Meadowbrook Insurance Group Inc and ProCentury Corporation Reach Agreement to Merge in 24272 6 Million Transaction 12388 2Meadowbrook Insurance Group Inc and ProCentury Corporation Reach Agreement to Merge in 24272 6 Million Transaction 12388 3Meadowbrook Insurance Group Inc and ProCentury Corporation Reach Agreement to Merge in 24272 6 Million Transaction 12388 4Meadowbrook Insurance Group Inc and ProCentury Corporation Reach Agreement to Merge in 24272 6 Million Transaction 12388 5Meadowbrook Insurance Group Inc and ProCentury Corporation Reach Agreement to Merge in 24272 6 Million Transaction 12388 6Meadowbrook Insurance Group Inc and ProCentury Corporation Reach Agreement to Merge in 24272 6 Million Transaction 12388 7
...ther diagnostic regimes that were previously restr...lysis is entering the clinical mainstream. Smaller...fordable for hospital or large physicians group la...lable for primary point of care locations such as ... 310 Genetic Analyzer from Applied Biosystems, Fos...
...5, Chiron Corporation notified the CDC that none o...ble for distribution in the United States for the ...en removal of nearly half of the anticipated Ameri...ral public have grown increasingly alarmed about t...pidemic. , ,It remains to be seen if virulent ...
Other Medicine Technology:Genetic Analysis Systems Enter the Clinical Mainstream 2Genetic Analysis Systems Enter the Clinical Mainstream 3Rapid Flu Tests May Prove Especially Helpful This Season 2Rapid Flu Tests May Prove Especially Helpful This Season 3
...oped a range of Milli-Q ultrapure water systems de...s. Each of the five new Milli-Q systems is designe...to particular applications such as HPLC, molecular...h precision resistivity monitor that records condu...
...oped a range of Milli-Q ultrapure water systems de...s. Each of the five new Milli-Q systems is designe...to particular applications such as HPLC, molecular...h precision resistivity monitor that records condu...
...oped a range of Milli-Q ultrapure water systems de...s. Each of the five new Milli-Q systems is designe...to particular applications such as HPLC, molecular...h precision resistivity monitor that records condu...
...oped a range of Milli-Q ultrapure water systems de...s. Each of the five new Milli-Q systems is designe...to particular applications such as HPLC, molecular...h precision resistivity monitor that records condu...
Medicine Products: